Evidence map›Paper›PMID 40411623›Full record

ReviewIntensive care medicine2025

How to approach a patient hospitalized for pneumonia who is not responding to treatment?

Pedro Povoa, Luís Coelho, Jordi Carratala, Kelly Cawcutt, Sara E Cosgrove, Ricard Ferrer, Carlos A Gomez, Michael Klompas, Thiago Lisboa, Ignacio Martin-Loeches and 5 more

Erratum issuedAbstract readReview
In one paragraph

Review in Intensive care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Management of pneumonia by the emergency radiologist.European journal of radiology open · 2026
    Article
  3. Clinical metagenomics: a call to action.Intensive care medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Review
  8. Article
  9. CAP in the ICU: are they all in fact CAP?Intensive care medicine · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Persistent severe AKI is bad-where to go now?Intensive care medicine · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Pedro PovoaNOVA Medical School, CHRC, NOVA University of Lisbon, Lisbon, Portugal. pedro.povoa@nms.unl.pt.ORCID 0000-0002-7069-7304
Luís CoelhoNOVA Medical School, CHRC, NOVA University of Lisbon, Lisbon, Portugal.ORCID 0000-0003-0701-3624
Jordi CarratalaDepartment of Infectious Diseases, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0003-3209-2563
Kelly CawcuttDivision of Infectious Diseases & Pulmonary and Critical Care Medicine, University of Nebraska Medical Center, Omaha, USA.ORCID 0000-0003-3586-0951
Sara E CosgroveDepartment of Medicine, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, USA.ORCID 0000-0001-9458-4331
Ricard FerrerServei de Medicina Intensiva, SODIR Research Group, Hospital Universitari Vall d'Hebron, Institut de Recerca Vall d'Hebron, Barcelona, Spain.ORCID 0000-0002-4859-4747
Carlos A GomezDepartment of Internal Medicine, Division of Infectious Diseases, College of Public Health, University of Nebraska Medical Center, Omaha, USA.ORCID 0000-0001-5486-5710
Michael KlompasDepartment of Population Medicine, Harvard Medical School and Harvard Pilgrim Healthcare Institute, Boston, USA.ORCID 0000-0001-8641-4498
Thiago LisboaHospital de Clinicas de Porto Alegre, PPG Ciencias Pneumologicas, UFRGS, Porto Alegre, Brazil.ORCID 0000-0003-4306-2212
Ignacio Martin-LoechesMultidisciplinary Intensive Care, Department of Clinical Medicine, Trinity College, Wellcome Trust-HRB Clinical Research Facility, St James Hospital, St James's University Hospital, Dublin, Ireland.ORCID 0000-0002-5834-4063
Saad NseirMédecine Intensive-Réanimation, CHU de Lille, Lille, France.ORCID 0000-0002-7618-0357
Jorge I F SalluhNOVA Medical School, CHRC, NOVA University of Lisbon, Lisbon, Portugal.ORCID 0000-0002-8164-1453
Sias SchergerDepartment of Internal Medicine, Division of Infectious Diseases, College of Public Health, University of Nebraska Medical Center, Omaha, USA.ORCID 0000-0003-3299-855X
Daniel A SweeneyDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of California, La Jolla, San Diego, USA.ORCID 0000-0002-5398-3528
Andre C KalilDepartment of Internal Medicine, Division of Infectious Diseases, College of Public Health, University of Nebraska Medical Center, Omaha, USA.ORCID 0000-0002-6489-6294

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumonia is a frequent cause of intensive care unit (ICU) admission and is the most common infection in ICU patients across all geographic regions. It takes 48-72h for most patients to respond to appropriate antibiotic therapy. Non-response is typically defined as the persistence/worsening of clinical signs-such as fever, respiratory distress, impaired oxygenation and/or radiographic abnormalities-with rates ranging 20-30%. Several factors can contribute to non-response. Host factors, including immunosuppression, chronic lung disease, or ongoing aspiration, may impair resolution. Additionally, incorrect antibiotic dosing, atypical or resistant pathogens (such as multidrug-resistant bacteria, Mycobacterium tuberculosis, or fungal infections) may be responsible, requiring alternative antimicrobial strategies. A septic complication related to pneumonia (e.g., empyema) or not (e.g., acalculous cholecystitis) may need to be excluded. Finally, non-infectious conditions (e.g., pulmonary embolism, malignancy, secondary ARDS or vasculitis) that can mimic or potentiate pneumonia must be considered. Although non-responding pneumonia is frequent, its management lacks strong evidence, and its approach is based mostly on the art of medicine and clinical judgement. Clinicians should continuously reassess the medical history and physical exam, review microbiological data, and consider imaging such as chest CT. Bronchoscopy or repeat sputum sampling may aid in identifying alternative pathogens or non-infectious causes. The management of a non-responding pneumonia depends on the findings of a structured reassessment. Herein, we provide guidance on how to identify and manage non-responding pneumonia. Ultimately, addressing pneumonia that does not respond to antibiotics is crucial for preventing complications, optimizing antimicrobial stewardship, and improving patient outcomes.

Indexed as

Anti-Bacterial AgentsPneumoniaHospitalizationHumansIntensive Care UnitsAnti-Bacterial AgentsCommunity-acquired pneumoniaHospital-acquired pneumoniaManagementNonresponding pneumoniaPneumoniaVentilator-associated pneumonia

Identifiers

PMID40411623
PMCPMC12129858

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.